The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat

Cancer Lett. 1983 Nov;21(1):57-61. doi: 10.1016/0304-3835(83)90082-4.

Abstract

Male Lobund strain Sprague--Dawley (SD) rats respond to single doses of methylazoxymethanol acetate (MAM) with high incidence of intestinal tumors within 5 months. Some non-steroidal anti-inflammatory drugs (NSAIDs) can block the synthesis of prostaglandins (PGs) and also interfere with tumor growth. A new class of NSAID, piroxicam, was added to the feed of MAM-treated rats. When examined 150 days later, there was a significant reduction of tumor-bearing rats and of tumors/rat compared to controls on drug-free feed; and there was no evidence of toxicity.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Body Weight
  • Diet
  • Indomethacin / therapeutic use
  • Intestinal Neoplasms / chemically induced
  • Intestinal Neoplasms / drug therapy*
  • Intestinal Neoplasms / pathology
  • Male
  • Methylazoxymethanol Acetate
  • Piroxicam
  • Rats
  • Rats, Inbred Strains
  • Thiazines / pharmacology
  • Thiazines / therapeutic use*

Substances

  • Thiazines
  • Piroxicam
  • Methylazoxymethanol Acetate
  • Indomethacin